Resources

Resources

Contracting Implications for Cell & Gene Therapies

July 16, 2020 | 1:00 pm ET

Watch the Webinar

Access Password: IntegriChain-CEO_Council@20200716

Cell and Gene Therapy companies have unique pricing and contracting strategies that can impact government program access. Join IntegriChain’s Jeff Baab and as the do a “deep-dive” into contracting strategies and considerations. Topics to be explored include:

  • Key market considerations, such as payer coverage and policy trends
  • Techniques to maximize access to government and commercial channels
  • How coverage may change over time

 

Along with key market access considerations — such as payer coverage and policy trends — to maximize access to government and commercial channels.

Who should attend: Finance and Accounting Professionals, Contracting & Pricing Professionals, Market Access Executive Leadership

 

 

 

Jeff Baab         Josef Magpantay

Watch The Webinar

Access Password: IntegriChain-CEO_Council@20200716

CEO Council for Growth’s Cell & Gene Therapy and Connected Health Initiative, in partnership with IntegriChain, is pleased to announce a three-part educational webinar series designed specifically for emerging cell and gene therapy (CGT) firms. The focus will be on launch and commercialization preparedness.

Discovery and development are necessarily the focus during the earliest stages of development of CGTs, but careful market access plans are also essential if a therapeutic is to reach as many patients as possible. To support young companies and stimulate overall industry growth in this important subsector of the life sciences, experts from Philadelphia-based IntegriChain, a data and business process platform for therapy commercialization and access, will share their knowledge and experiences via this complimentary educational series running Summer 2020.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand